Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222

Author:

Singh Ashvani K.,Fan Yihong,Balut Corina,Alani Sara,Manelli Arlene M.,Swensen Andrew M.,Jia Ying,Neelands Torben R.,Vortherms Timothy A.,Liu Bo,Searle Xenia B.,Wang Xueqing,Gao Wenqing,Hwang Tzyh-Chang,Ren Hong Y.,Cyr Douglas,Kym Philip R.,Conrath Katja,Tse Chris

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference59 articles.

1. Sequential Quality-Control Checkpoints Triage Misfolded Cystic Fibrosis Transmembrane Conductance Regulator

2. Tezacaftor/ivacaftor (SYMDEKO) for cystic fibrosis;Med Lett Drugs Ther,2018

3. Altenbach R Bogdan A Greszler S Koenig J Kym P Liu B Searle X Voight E Wang X Yeung C (2016) Preparation of substituted chromanes as CFTR modulators useful in treatment of diseases, United States Patent US9642831B2

4. Human primary epithelial cell models: promising tools in the era of cystic fibrosis personalized medicine;Awatade;Front Pharmacol,2018

5. Balut CM Akkari R Alani S Bock X Bogdan A Claes P Cowart MD Couty S De Lemos E Desroy N (2017) Development and characterization of next-generation correctors as part of a triple CF therapy. Pediatr Pulmonol 52 Abstract 198: 286

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3